Skip to main content
Top
Literature
1.
go back to reference Poddar U, Bhattacharya A, Thapa BR, Mittal BR, Singh K. Ursodeoxycholic acid-augmented hepatobiliary scintigraphy in the evaluation of neonatal jaundice. J Nucl Med. 2004;45(9):1488–92.PubMed Poddar U, Bhattacharya A, Thapa BR, Mittal BR, Singh K. Ursodeoxycholic acid-augmented hepatobiliary scintigraphy in the evaluation of neonatal jaundice. J Nucl Med. 2004;45(9):1488–92.PubMed
2.
go back to reference Khorasani EN, Mansouri F. Application of ursodeoxycholic acid in hepatobiliary scintigraphy for neonatal hyperbilirubinemia: comparison with phenobarbital. Iran J Nucl Med. 2009;17(2):20–5. Khorasani EN, Mansouri F. Application of ursodeoxycholic acid in hepatobiliary scintigraphy for neonatal hyperbilirubinemia: comparison with phenobarbital. Iran J Nucl Med. 2009;17(2):20–5.
3.
go back to reference Poddar U, Thapa BR, Das A, Bhattacharya A, Rao KL, Singh K. Neonatal cholestasis: differentiation of biliary atresia from neonatal hepatitis in a developing country. Acta Paediatr. 2009;98(8):1260–4.CrossRefPubMed Poddar U, Thapa BR, Das A, Bhattacharya A, Rao KL, Singh K. Neonatal cholestasis: differentiation of biliary atresia from neonatal hepatitis in a developing country. Acta Paediatr. 2009;98(8):1260–4.CrossRefPubMed
4.
go back to reference Jafri S, Pasricha P. Agents used for diarrhea, constipation and inflammatory bowel disease; agents used for biliary and pancreatic disease. In: Hardman JG, Limberd LE, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 1037–55. Jafri S, Pasricha P. Agents used for diarrhea, constipation and inflammatory bowel disease; agents used for biliary and pancreatic disease. In: Hardman JG, Limberd LE, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 1037–55.
5.
go back to reference Altman DF. Drugs used in gastrointestinal diseases. In: Katzung BG, editor. Basic and clinical pharmacology. 8th ed. New York: Lange Medical Books/McGraw-Hill; 2001. p. 1064–75. Altman DF. Drugs used in gastrointestinal diseases. In: Katzung BG, editor. Basic and clinical pharmacology. 8th ed. New York: Lange Medical Books/McGraw-Hill; 2001. p. 1064–75.
6.
go back to reference Romero Maldonado S, Godínez Téllez NC, Yescas-Buendía G, Fernández-Carrocera LA, Echaniz Avilés MO, Reyna Ríos ER. Effectiveness of ursodeoxycholic acid versus phenobarbital for the treatment of neonatal cholestasis: a cross-randomized clinical trial. Bol Med Hosp Infant Mex. 2010;67:422–9. Romero Maldonado S, Godínez Téllez NC, Yescas-Buendía G, Fernández-Carrocera LA, Echaniz Avilés MO, Reyna Ríos ER. Effectiveness of ursodeoxycholic acid versus phenobarbital for the treatment of neonatal cholestasis: a cross-randomized clinical trial. Bol Med Hosp Infant Mex. 2010;67:422–9.
Metadata
Title
Ursodeoxycholic acid versus phenobarbital pretreatment prior to hepatobiliary scintigraphy in neonatal cholestasis: is it time for shifting gears towards a practice change?
Authors
Sandip Basu
Anish Bhattacharya
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 7/2015
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-015-3011-z

Other articles of this Issue 7/2015

European Journal of Nuclear Medicine and Molecular Imaging 7/2015 Go to the issue